Concordia Healthcare CFO Adrian de Saldanha to leave
Mr. de Saldanha is a Chartered Professional Accountant (CPA, CA) with extensive experience as a senior finance executive in roles covering a variety of industries.
He was Chief Financial Officer at Syncordia Technologies and Healthcare Solutions, previous to which he was a Managing Vice President at OMERS Strategic Investments.
Mr. de Saldanha also spent over seven years at Biovail Corporation (now Valeant Pharmaceuticals) in a number of senior finance roles including Interim Chief Financial Officer, Vice President Finance & Treasurer, Vice President Manufacturing Finance as well as Vice President, Controller at Biovail Pharmaceuticals Canada.
Before joining Biovail, Mr. de Saldanha spent eight years at Molson Inc. in a number of progressively senior finance positions.
Mr. de Saldanha will be replaced by Concordia's current Executive Vice President, Edward Borkowski.
Mr. Borkowski is a healthcare executive who previously was the CFO of Amerigen Pharmaceuticals, a generic pharmaceutical company with a focus on oral controlled release products.
Prior to working with Amerigen, he was the CFO and Executive Vice President of Mylan N.V.
In addition, Mr. Borkowski previously held the position of CFO with Convatec, a global medical device company focused on wound care and ostomy, and Carefusion, a global medical device company for which he helped lead its spin-out from Cardinal health into an independent public company.
Mr. Borkowski also held senior financial positions at Pharmacia and American Home Products (Wyeth). He started his career with Arthur Andersen & Co. after graduating from Rutgers University with an MBA in accounting.
Mr. Borkowski also graduated from Allegheny College with a degree in Economics and Political Science. He is a Trustee and an Executive Committee member of Allegheny College. ■
What to read next
LATEST MOVES FROM Ontario
- Canada Goose appoints John Davison to board
- Sphere 3D appoints Cheemin Bo-Linn to board
- Ascendant Resources appoints Mark Brennan as executive chairman
- Titan Medical appoints Curtis R. Jensen as vice president
- Manulife promotes Roy Gori to president
More inside POST